Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dougan

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
European Radiology|June 3, 2021
Multi-detector computed tomography (MDCT)-based severity score as a prognostic tool in patients with suspected immune checkpoint inhibitor therapy associated colitisNisanard Pisuchpen, Sienna M Durbin, Meghan J Mooradian, et al.
Blood|May 8, 2007
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cellsThomas Enzler, Silke Gillessen, Michael Dougan, et al.
Open Forum Infectious Diseases|December 10, 2021
Bamlanivimab Efficacy in Older and High-BMI Outpatients With COVID-19 Selected for Treatment in a Lottery-Based Allocation ProcessEmily B Rubin, Jonathan A Boiarsky, Lauren A Canha, et al.
Contemporary Clinical Trials|September 24, 2022
The association between non-English primary language and COVID-19 clinical trial eligibility and enrollment: A retrospective cohort studySarah D Tait, Chana A Sacks, Michael Dougan, et al.
Open Forum Infectious Diseases|July 1, 2022
Performance of a Triage Protocol for Monoclonal Antibodies in a Mixed Vaccinated and Unvaccinated Cohort of COVID-19 Patients Treated With Intravenous Infusion or Subcutaneous InjectionEmily B Rubin, Mofei Liu, Anita Giobbie-Hurder, et al.
Journal for Immunotherapy of Cancer|November 9, 2019
Budesonide treatment for microscopic colitis from immune checkpoint inhibitorsMichael S Hughes, Gabriel E Molina, Steven T Chen, et al.
The Oncologist|February 17, 2026
Impact of immune checkpoint inhibition on ovarian reserveElizabeth I Buchbinder, Zihe Song, Justine V Cohen, et al.
Annals of Surgery|September 17, 2020
The Association Between Symptoms and COVID-19 Test Results Among Healthcare WorkersChana A Sacks, Michael Dougan, Thomas H McCoy, et al.
Immunotherapy Advances|July 18, 2023
Blockade of innate inflammatory cytokines TNF<b>α</b>, IL-1<b>β</b>, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regressionMichael J Walsh, Lestat R Ali, Patrick Lenehan, et al.
Cell Reports|March 7, 2023
IFNγ is a central node of cancer immune equilibriumMichael J Walsh, Courtney T Stump, Rakeeb Kureshi, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
European Radiology|June 3, 2021
Multi-detector computed tomography (MDCT)-based severity score as a prognostic tool in patients with suspected immune checkpoint inhibitor therapy associated colitisNisanard Pisuchpen, Sienna M Durbin, Meghan J Mooradian, et al.
Blood|May 8, 2007
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cellsThomas Enzler, Silke Gillessen, Michael Dougan, et al.
Open Forum Infectious Diseases|December 10, 2021
Bamlanivimab Efficacy in Older and High-BMI Outpatients With COVID-19 Selected for Treatment in a Lottery-Based Allocation ProcessEmily B Rubin, Jonathan A Boiarsky, Lauren A Canha, et al.
Contemporary Clinical Trials|September 24, 2022
The association between non-English primary language and COVID-19 clinical trial eligibility and enrollment: A retrospective cohort studySarah D Tait, Chana A Sacks, Michael Dougan, et al.
Open Forum Infectious Diseases|July 1, 2022
Performance of a Triage Protocol for Monoclonal Antibodies in a Mixed Vaccinated and Unvaccinated Cohort of COVID-19 Patients Treated With Intravenous Infusion or Subcutaneous InjectionEmily B Rubin, Mofei Liu, Anita Giobbie-Hurder, et al.
Journal for Immunotherapy of Cancer|November 9, 2019
Budesonide treatment for microscopic colitis from immune checkpoint inhibitorsMichael S Hughes, Gabriel E Molina, Steven T Chen, et al.
The Oncologist|February 17, 2026
Impact of immune checkpoint inhibition on ovarian reserveElizabeth I Buchbinder, Zihe Song, Justine V Cohen, et al.
Annals of Surgery|September 17, 2020
The Association Between Symptoms and COVID-19 Test Results Among Healthcare WorkersChana A Sacks, Michael Dougan, Thomas H McCoy, et al.
Immunotherapy Advances|July 18, 2023
Blockade of innate inflammatory cytokines TNF<b>α</b>, IL-1<b>β</b>, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regressionMichael J Walsh, Lestat R Ali, Patrick Lenehan, et al.
Cell Reports|March 7, 2023
IFNγ is a central node of cancer immune equilibriumMichael J Walsh, Courtney T Stump, Rakeeb Kureshi, et al.
Pageof 15